Drawing for IOVANCECARES

USPTO serial 98244548

IOVANCECARES

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
YAO, GRETTA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with IOVANCECARES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,892*

Plus Government fees of $1,000

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carla B. Oakley

Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP600 Montgomery Street, Suite 2300SAN FRANCISCO, CA 94111United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disordersACTIVE—
009recorded computer software, downloadable computer software and downloadable mobile applications for data analysis for immunotherapy treatments and research; recorded computer software, downloadable computer software and downloadable mobile applications for tracking and monitoring chain of custody and chain of identity of cell therapies; recorded computer software, downloadable computer software and downloadable mobile applications for scheduling and tracking medical patient appointments, medical and healthcare services and medical laboratory services, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; recorded computer software, downloadable computer software and downloadable mobile applications for processing medication reimbursement and payer assistance services, patient support services, and hospital support services; recorded computer software, downloadable computer software and downloadable mobile applications for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing referrals in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for messaging and chat in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for locating doctors, physician's assistants, nurses, nutritionists, therapists, healthcare professionals and healthcare service providers; recorded computer software, downloadable computer software and downloadable mobile applications for providing medical diagnosis, consultation, treatment recommendations, and medical care services and information; recorded computer software, downloadable computer software and downloadable mobile applications for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatmentsACTIVE—
035medical appointment scheduling services; confirming scheduled appointments for others in the field of cancer treatments; physician referral services; hospital referral services; providing online physician and hospital directories on the internet; processing of online orders of prescriptionsACTIVE—
036financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services; providing information regarding pharmaceutical cost reimbursements; providing assistance to patients regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverageACTIVE—
038telecommunications services, namely, transmission of voice, audio, data, graphics, and video between patients and healthcare providers via global and local computer networks in the fields of telehealth, telemedicine, remote care, and virtual health care services; providing users with real-time and on-demand access to health care professionals via computer, telephone, and other electronic means via telecommunication networksACTIVE—
042providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for matching patients and medical treatment sites, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; providing an interactive website featuring technology that allows users to communicate with patients and manage patient treatment data, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; software as a service (SaaS) services featuring software for delivering streamlined medical treatment information and improving communication among stakeholders in medical treatment and medical research; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; providing temporary use of non-downloadable software for providing medical referrals; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care, and virtual health care services; software as a service (SAAS) services featuring software for scheduling medical and healthcare services; software as a service (SAAS) services featuring software for providing consultation, and medical care services and information; providing temporary use of on-line non-downloadable software for remote medical consultation in the field of telemedicine; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the medical and healthcare fields; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatmentsACTIVE—
044medical services, namely, resection of tumor and modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services; providing a web site featuring medical information and information relating to pharmaceuticals; providing medical and health information relating to pharmaceuticals; medical, telehealth, remote care and virtual health care services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, and mobile wireless devices via video, email, or a global computer network; providing medical services, telehealth services in the nature of telemedicine services, remote health care services, and virtual health care services via a web site and mobile app featuring health and medical information; providing telemedicine and virtual health care services for the diagnosis, consultation, and treatment of oncological or immune system conditions; medical counseling; consulting services in the field of medical care; medical, immunotherapy and pharmaceutical consultation; medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVE—
045providing patient advocate and case management services in the field of oncology and immunotherapy treatmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (EEXT): The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.

DateCodeEventWhat it means
Nov 9, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2026EX4GSOU EXTENSION 4 GRANTED—
May 7, 2026EXT4SOU EXTENSION 4 FILED—
May 7, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 7, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 7, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 6, 2025EX3GSOU EXTENSION 3 GRANTED—
Nov 6, 2025EXT3SOU EXTENSION 3 FILED—
Nov 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2025EX2GSOU EXTENSION 2 GRANTED—
May 6, 2025EXT2SOU EXTENSION 2 FILED—
May 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 7, 2024EX1GSOU EXTENSION 1 GRANTED—
Nov 7, 2024EXT1SOU EXTENSION 1 FILED—
Nov 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2024DOCKASSIGNED TO EXAMINER—
Nov 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance